Anzeige
Mehr »
Login
Donnerstag, 31.10.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Neuer Gold Rekord bei knapp 2.800 USD und Übernahme-Zirkus!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A4A520 | ISIN: CH1382892102 | Ticker-Symbol: FUTR
Düsseldorf
31.10.24
14:16 Uhr
20,280 Euro
-0,270
-1,31 %
1-Jahres-Chart
21SHARES FUTURE OF CRYPTO INDEX ETP Chart 1 Jahr
5-Tage-Chart
21SHARES FUTURE OF CRYPTO INDEX ETP 5-Tage-Chart
GlobeNewswire (Europe)
134 Leser
Artikel bewerten:
(0)

21Shares Grows its European Crypto ETP Lineup with the Launch of Future of Crypto Index ETP (FUTR)

ZURICH, 10 October 2024 - 21Shares AG ("21Shares"), one of the world's largest issuers of crypto exchange traded products (ETPs), today announced the launch of the 21Shares Future of Crypto Index ETP (FUTR) on Euronext Paris and Euronext Amsterdam. FUTR represents the latest addition to its growing European product lineup, representing the firm's 44th crypto ETP, its 10th crypto basket ETP, and its first-ever crypto megatheme ETP.

ExchangeProduct NameTickerISINFee
Euronext Paris21Shares Future of Crypto Index ETPFUTR FPCH13828921021.49%
Euronext Amsterdam21Shares Future of Crypto Index ETPFUTR NACH13828921021.49%

"Global excitement, demand and momentum for crypto is undeniable. And 21Shares has been at the forefront of increasing global access to the crypto asset class since inception in 2018 - offering investors a six-year track record of developing, launching and managing crypto ETPs," said Hany Rashwan, Co-Founder and CEO of 21Shares. "As 21Shares' first-ever crypto megatheme ETP, FUTR represents the next evolution of the firm's European product lineup and a potential opportunity for investors looking for the next step after allocating to Bitcoin (BTC) and Ethereum (ETH)."

Rashwan continued: "With the launch of FUTR, 21Shares is thrilled to leverage the firm's world-class product development and research capabilities to bring investors access to a future-oriented, broad-based index offering easy exposure to the most promising sectors of the crypto ecosystem."

FUTR provides investors with comprehensive exposure to the top sectors and themes anticipated to drive the future growth of the crypto market. By tracking a broad-based index that covers over 80% of the market, the ETP offers exposure to six key megathemes expected to drive long-term growth in the crypto market:

  1. Payment Platforms: Payment platforms are blockchains or protocols specialized in transferring value.
  2. Smart Contract Platforms: A smart contract platform is a base blockchain with built-in general-purpose programmability that allows developers to write smart contracts and launch decentralized applications (dApps).
  3. Blockchain Accelerators: A blockchain accelerator is a separate blockchain that helps augment the network capacity of a settlement blockchain by orders of magnitude while inheriting the security guarantees of the latter.
  4. Decentralized Finance (DeFi): Decentralized finance is internet-native financial infrastructure that does not rely on a centralized institution such as a bank, broker, or similar intermediaries.
  5. AI and Data Solutions: This refers to platforms that leverage artificial intelligence and data technologies to enhance various aspects of crypto ecosystems.
  6. Social and Gaming: This refers to an overlaying sector between blockchain, crypto, and the gaming industries, along with social elements that enhance player interactions and community building.

FUTR takes a market-capitalization weighted approach, with leading assets from each of these six megathemes. In addition, FUTR offers dynamic allocation, a strategy that evolves with the market to provide alignment with emerging trends and opportunities. Further, FUTR excludes meme tokens, privacy tokens and assets below a $2M liquidity threshold, focusing on quality investments. FUTR is 100% physically backed by the underlying assets stored securely in cold storage by an institutional-grade custodian, offering enhanced protection.

21Shares worked with MarketVector Indexes as the index provider for FUTR. MarketVector Indexes brings deep market knowledge in crypto indices to the digital assets landscape.

"The 21Shares Future of Crypto Index provides a dynamic framework for tracking key sectors driving the next phase of crypto growth. We're excited to partner with 21Shares on this forward-thinking, innovative product", said Steven Schoenfeld, CEO of MarketVector Indexes.

The launch of FUTR also represents an expansion of 21Shares' collaboration with Flow Traders, who will act as the market maker for the product.

"This is another step forward in supporting the broader adoption of digital assets, and we are thrilled to continue to expand our role in being the leading liquidity provider in the crypto ETP space as well as our partnership with 21Shares," said Michael Lie, Global Head of Digital Assets at Flow Traders. "Innovative products like FUTR with diversified exposure to key themes in crypto, much like sector ETFs in TradFi, are going to be essential in expanding the full reach of digital assets and its value to financial markets. In our role, we will continue supporting innovative products and driving the convergence of TradFi and crypto."

For more details about the 21Shares Future of Crypto Index ETP, including the factsheet, please click here.

Press Contact

Audrey Belloff, Head of Global Communications, audrey.belloff@21.co

About 21.co / 21Shares

21.co is the world's leader in providing access to crypto through simple and easy to use products. 21.co is the parent company of 21Shares, one of the world's largest issuers of crypto exchange traded products (ETPs) - which is powered by Onyx, a proprietary technology platform used to issue and operate cryptocurrency ETPs for 21Shares and third parties. The company was founded in 2018 by Hany Rashwan and Ophelia Snyder. 21Shares is registered in Zurich, Switzerland with offices in Zurich, London and New York. For more information, please visit 21Shares.

About MarketVector Indexes - www.marketvector.com

MarketVector IndexesTM ("MarketVector") is a regulated Benchmark Administrator in Europe, incorporated in Germany and registered with the Federal Financial Supervisory Authority (BaFin). MarketVector maintains indexes under the MarketVectorTM, MVIS®, and BlueStar® names. With a mission to accelerate index innovation globally, MarketVector is best known for its broad suite of Thematic indexes, a long-running expertise in Hard Asset-linked Equity indexes, and its pioneering Digital Asset index family. MarketVector is proud to be in partnership with more than 25 Exchange Traded Product (ETP) issuers and index fund managers in markets throughout the world, with more than USD 50 billion in assets under management.

About Flow Traders

Flow Traders is a leading multi-asset market maker founded more than twenty years ago, the firm expanded into digital assets trading in 2017, focusing on centralized exchanges before expanding its operations to include over-the-counter trading, options trading and decentralized finance. Additionally, Flow Traders strategically invests in builders and teams driving the convergence of centralized and decentralized finance.

DISCLAIMER

This document is not an offer to sell or a solicitation of an offer to buy or subscribe for securities of 21Shares AG in any jurisdiction. Neither this document nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever or for any other purpose in any jurisdiction. Nothing in this document should be considered investment advice.

This document and the information contained herein are not for distribution in or into (directly or indirectly) the United States, Canada, Australia or Japan or any other jurisdiction in which the distribution or release would be unlawful.

This document does not constitute an offer of securities for sale in or into the United States, Canada, Australia or Japan. The securities of 21Shares AG to which these materials relate have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There will not be a public offering of securities in the United States. Neither the US Securities and Exchange Commission nor any securities regulatory authority of any state or other jurisdiction of the United States has approved or disapproved of an investment in the securities or passed on the accuracy or adequacy of the contents of this presentation. Any representation to the contrary is a criminal offence in the United States.

Within the United Kingdom, this document is only being distributed to and is only directed at: (i) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"); or (ii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as "relevant persons"); or (iii) persons who fall within Article 43(2) of the Order, including existing members and creditors of the Company or (iv) any other persons to whom this document can be lawfully distributed in circumstances where section 21(1) of the FSMA does not apply. The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.

Exclusively for potential investors in any EEA Member State that has implemented the Prospectus Regulation (EU) 2017/1129 the Issuer's Base Prospectus (EU) is made available on the Issuer's website under www.21Shares.com.

The approval of the Issuer's Base Prospectus (EU) should not be understood as an endorsement by the SFSA of the securities offered or admitted to trading on a regulated market. Eligible potential investors should read the Issuer's Base Prospectus (EU) and the relevant Final Terms before making an investment decision in order to understand the potential risks associated with the decision to invest in the securities. You are about to purchase a product that is not simple and may be difficult to understand.

This document constitutes advertisement within the meaning of the Prospectus Regulation (EU) 2017/1129 and the Swiss Financial Services Act (the "FinSA") and not a prospectus. The 2023 Base Prospectus of 21Shares AG has been deposited pursuant to article 54(2) FinSA with SIX Exchange Regulation AG in its function as Swiss prospectus review body within the meaning of article 52 FinSA. The 2023 Base Prospectus and the key information document for any products may be obtained at 21Shares AG's website (https://21shares.com/ir/prospectus or https://21shares.com/ir/kids).

###


© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.